Rasna Therapeutics Inc. | |
Stock Exchange | Other OTC |
EPS |
$0.03 |
Market Cap |
$36.52 M |
Shares Outstanding |
68.91 M |
Public Float |
35.38 M |
Address |
420 Lexington Avenue New York New York 10170 United States |
Employees | - |
Website | http://www.rasna.com |
Updated | 07/08/2019 |
Rasna Therapeutics, Inc. engages in the provision of medical development. Its activities include research and development of treatment for leukemia and other cancers. It involves in modulating the molecular targets NPM1 and LSD1, which are implicated in the disease progression of leukemia and lymphoma. |